Filing Details

Accession Number:
0000903423-19-000257
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-26 10:46:51
Reporting Period:
2019-06-24
Accepted Time:
2019-06-26 10:46:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1457612 Genocea Biosciences Inc. GNCA Pharmaceutical Preparations (2834) X0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1131399 Plc Glaxosmithkline 980 Great West Road
Brentford Middlesex X0 TW8 9GS
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-24 1,857,142 $3.50 3,365,884 No 4 P Indirect See Footenote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footenote
Footnotes
  1. S.R. One, Limited acquired 1,857,142 shares of Common Stock of Genocea Biosciences, Inc. (the "Issuer") in connection with the Issuer's public offering.
  2. The shares reported herein are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (the "Reporting Person").